Back to Search
Start Over
Understanding the role of non-coding RNA (ncRNA) in stent restenosis.
- Source :
-
Atherosclerosis (00219150) . May2018, Vol. 272, p153-161. 9p. - Publication Year :
- 2018
-
Abstract
- Coronary heart disease (CHD) is one of the leading disorders with the highest mortality rate. Percutaneous angioplasty and stent implantation are the currently available standard methods for the treatment of obstructive coronary artery disease. However, the stent being an exogenous substance causes several complications by promoting the proliferation of vascular smooth muscle cells, immune responses and neointima formation after implantation, leading to post-stent restenosis (ISR) and late thrombosis. The prevention of these adverse vascular events is important to achieve long-term proper functioning of the heart after stent implantation. Non-coding ribonucleic acids (ncRNAs) are RNA molecules not translated into proteins, theyhave a great potential in regulating endothelial cell and vascular smooth muscle function as well as inflammatory reactions. In this review, we outline the regulatory functions of different classes of ncRNA in cardiovascular disease and propose ncRNAs as new targets for stent restonosis treatment. [ABSTRACT FROM AUTHOR]
- Subjects :
- *CORONARY restenosis
*NON-coding RNA
*IMMUNE response
*INFLAMMATION
*MICRORNA
Subjects
Details
- Language :
- English
- ISSN :
- 00219150
- Volume :
- 272
- Database :
- Academic Search Index
- Journal :
- Atherosclerosis (00219150)
- Publication Type :
- Academic Journal
- Accession number :
- 129072511
- Full Text :
- https://doi.org/10.1016/j.atherosclerosis.2018.03.036